DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for Tessier number 4 facial cleft — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleTessier number 4 facial cleft maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for tessier number 4 facial cleft is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
A literature review of 72 Tessier 30 facial cleft cases published between 1996 and 2020 found no universally accepted surgical management strategy. Of the 72 cases, only 31 had documented completed repair of the cleft. All 11 soft-tissue-only defects were repaired in a single stage. Where both soft tissue and mandible were involved (20 cases), 55% (11 cases) had undergone one-stage repair. The authors argue that a single-stage approach is preferable to multistage, and recommend primary mucogingivoperiosteoplasty in the latter half of the first year of life.
A separate 2025 case series assessed presurgical infant orthopedics (PSIO) in three patients with Tessier clefts. The authors report that cleft width and premaxilla reduction were observed in all three patients. They note that treatment outcomes for Tessier clefts remain limited, resulting in a higher burden of care and lower quality of life, and that PSIO application to these clefts is underreported.
No abstract in the provided set addresses Tessier number 4 facial cleft specifically. The available literature covers Tessier 30 clefts and general Tessier clefts, not the number 4 variant. No drug, medication, or pharmacological intervention is mentioned in any of the abstracts.
What is still missing is any prospective or controlled data on Tessier number 4 clefts, a standardised classification system that separates outcomes by cleft type, and funding for multicentre registries that could collect enough cases to compare surgical approaches. No randomised trial design exists for this condition, and patient stratification by cleft severity and associated anomalies remains undefined.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
The Cleft Palate-Craniofacial Journal · 2021 · 6 citations
Tessier 30 Facial Clefts—A Literature Review of 72 Cases (1996-2020), Suggested Treatment Protocol, Outcome Measures, Minimum Dataset for Future Case Reports, and Registries
AbstractINTRODUCTION: Tessier 30 facial cleft is a rare anomaly presenting in the soft and hard tissues over the central lower face. Owing to the rarity of cases and difficulty of treatment, there is no universally accepted surgical management strategy. The last comprehensive literature review of Tessier 30 clefts was in 1996. This report aims to update the literature to inform decision-making on treating Tessier 30 cases. METHODOLOGY: A literature search was performed. PubMed, SCOPUS, and OVID databases were searched. A total of 72 cases in 51 articles were analyzed, looking at demographics, extent of cleft, parent health, family history, procedures, follow-up, existence of other anomalies, and stages of repair. RESULTS: Surgeons are increasingly choosing to repair Tessier 30 defects in one rather than multiple stages. Of the 72 cases studied, only 31 had documented the completed repair of the cleft. All completed soft tissue only defects were repaired in 1 stage of repair (n = 11). Where both soft tissue and mandible was involved (n = 20), 55% (n = 11) had undergone 1-stage repair to address the Tessier 30 cleft. DISCUSSION: We argue that a single-stage approach is preferable to multistage. Primary mucogingivoperiosteoplasty should be undertaken in children at the time of management of the soft tissue cleft. The timing of this procedure should be in the latter half of the first year of life, as this is when mandibular symphyseal fusion normally occurs. We have suggested a treatment protocol and we hope that future case reports use our minimum data set.
Supplemental Material, sj-pdf-1-cpc-10.1177_10556656211019237 - Tessier 30 Facial Clefts—A Literature Review of 72 Cases (1996-2020), Suggested Treatment Protocol, Outcome Measures, Minimum Dataset for Future Case Reports, and Registries
AbstractSupplemental Material, sj-pdf-1-cpc-10.1177_10556656211019237 for Tessier 30 Facial Clefts—A Literature Review of 72 Cases (1996-2020), Suggested Treatment Protocol, Outcome Measures, Minimum Dataset for Future Case Reports, and Registries by Ruben van der Valk, Stephen Magill, Annie Pellatt, Nazanin Ahmadi-Lari, Simon P. Hall, Alistair R. M Cobb and Tom W. M. Walker in The Cleft Palate-Craniofacial Journal
The Cleft Palate-Craniofacial Journal · 2025 · 0 citations
Presurgical Infant Orthopedics Appliance in Complex Craniofacial Deformity Involving Complete Cleft Lip and Palate Patients: A Case Series
AbstractTessier facial clefts are rare congenital abnormalities and among the most challenging deformities treated by craniofacial surgeons. Despite various surgical interventions, treatment outcomes remain limited, resulting in a higher burden of care and lower quality of life. PreSurgical Infant Orthopedics (PSIO) has shown benefits in cleft care, but its application to Tessier clefts is underreported. This report assesses the long-term surgical outcomes of 3 patients with Tessier clefts who underwent PSIO. The cleft width and premaxilla reduction were observed in all 3 patients.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
